Skip to content

Drug interactions

Denosumab + Sirolimus

Severity: Moderate

Denosumab and Sirolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sirolimus is an immunosuppressant that raises infection risk, and denosumab has been linked to serious infections. Combined use, for example in transplant recipients, may increase infection risk.

What this interaction means in plain words

Denosumab and Sirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Denosumab belongs to Oncology; Sirolimus belongs to Miscellaneous.

Evidence level: Low

Why it happens

Additive pharmacodynamic effect: mTOR-mediated immunosuppression plus RANKL inhibition affecting immune cells.

What to do

Monitor for infection, including skin and opportunistic infections, and treat promptly. Weigh the need for denosumab against infection risk in transplant patients.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Denosumab and Sirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Denosumab with Sirolimus?

MediHelp rates the interaction as moderate. Denosumab and Sirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sirolimus is an immunosuppressant that raises infection risk, and denosumab has been linked to serious infections. Combined use, for example in transplant recipients, may increase infection risk.

How serious is the interaction between Denosumab and Sirolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for infection, including skin and opportunistic infections, and treat promptly. Weigh the need for denosumab against infection risk in transplant patients.

What other medicines interact with Denosumab?

MediHelp also lists interactions of Denosumab with, for example, Abatacept, Adalimumab, Alefacept. The full list is on the Denosumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in